Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 18 medicines
- Artiss10ML · Solution · Baxter Healthcare Corporation
- Artiss4ML · Solution · Baxter Healthcare Corporation
- Artiss2ML · Solution · Baxter Healthcare Corporation
- Tisseel86.5 MG/ML Fibrinogen; 3000 KIU/ML Fibrinolysis Inh; 500 U/ML Thrombin · For Solution · Baxter Healthcare Corporation
All medicines with Fibrin sealant
Every register, a page at a time. Strengths and packs are on each medicine’s page.
24 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Vistaseal | United States | 6ML | Frozen | Marketed | Instituto Grifols, S.A. |
| Vistaseal | United States | 4ML | Frozen | Marketed | Instituto Grifols, S.A. |
| Vistaseal | United States | 10ML | Frozen | Marketed | Instituto Grifols, S.A. |
| Vistaseal | United States | 2ML | Frozen | Marketed | Instituto Grifols, S.A. |
| Artiss | United States | 2ML | Solution | Marketed | Baxter Healthcare Corporation |
| Artiss | United States | 4ML | Solution | Marketed | Baxter Healthcare Corporation |
| Artiss | United States | 10ML | Solution | Marketed | Baxter Healthcare Corporation |
| Tisseel | United States | 86.5 MG/ML Fibrinogen; 3000 KIU/ML Fibrinolysis Inh; 500 U/ML Thrombin | Solution | Marketed | Baxter Healthcare Corporation |
| Tisseel | United States | 86.5 MG/ML Fibrinogen; 3000 KIU/ML Fibrinolysis Inh; 500 U/ML Thrombin | For Solution | Marketed | Baxter Healthcare Corporation |
| Artiss | United States | 10ML | For Solution | Not marketed | Baxter Healthcare Corporation |
| Artiss | United States | 4ML | For Solution | Not marketed | Baxter Healthcare Corporation |
| Artiss | United States | 2ML | For Solution | Not marketed | Baxter Healthcare Corporation |
| Crosseal, Evicel | United States | 1ML | Spray | Withdrawn | Omrix Biopharmaceuticals Ltd |
| Crosseal, Evicel | United States | 2ML | Spray | Withdrawn | Omrix Biopharmaceuticals Ltd |
| Crosseal, Evicel | United States | 5ML | Spray | Withdrawn | Omrix Biopharmaceuticals Ltd |
| Raplixa | United States | 0.5G | Powder | Withdrawn | Mallinckrodt Pharma IP Trading DAC |
| Raplixa | United States | 1G | Powder | Withdrawn | Mallinckrodt Pharma IP Trading DAC |
| Raplixa | United States | 2G | Powder | Withdrawn | Mallinckrodt Pharma IP Trading DAC |
| Evarrest | United States | 55.5MG FIBRINOGEN&241.9IU THROMBIN/IN^2; 2x4 IN | Patch | Marketed | Ethicon, Inc. |
| Tachosil | United States | 9.5 CM X 4.8 CM MG PER CM2 FOR FIBRINOGEN; IU PER CM2 FOR THROMBIN | Patch | Marketed | Corza Medical GmbH |
| Tachosil | United States | 4.8 CM X 4.8 CM MG PER CM2 FOR FIBRINOGEN; IU PER CM2 FOR THROMBIN | Patch | Marketed | Corza Medical GmbH |
| Evarrest | United States | 50.3MG FIBRINOGEN&203.2IU THROMBIN/IN^2; 4x4 IN | Patch | Not marketed | Ethicon, Inc. |
| Evarrest | United States | 55.5MG FIBRINOGEN&241.9IU THROMBIN/IN^2; 4x4 IN | Patch | Not marketed | Ethicon, Inc. |
| Tachosil | United States | 3.0 CM X 2.5 CM MG PER CM2 FOR FIBRINOGEN; IU PER CM2 FOR THROMBIN | Patch | Not marketed | Corza Medical GmbH |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Sources
Compiled by Prognia from the public medicine registers of FDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 1
- Medicines
- 18
- Companies
- 4